Literature DB >> 1568122

Covariance adjustment of survival curves based on Cox's proportional hazards regression model.

J Lee1, C Yoshizawa, L Wilkens, H P Lee.   

Abstract

Cox's proportional hazards regression model is a useful statistical tool for the analysis of 'survival data' from longitudinal studies. This multivariate method compares the 'survival experience' between two or more exposure groups while allowing for simultaneous adjustment of confounding due to one or more covariates. In addition to the summary regression statistics, further insight on the exposure--response relationship can be gained by visually examining the covariates-adjusted survival curves in the respective comparison groups. Covariates-adjusted survival curves are usually computed by the 'average covariate method'. This method is, however, subject to potential drawbacks. A method that avoids these drawbacks is to estimate adjusted survival curves by the corrected group prognostic curves approach. We have written a computer program to construct survival curves by the latter method. The program is coded in the Interactive Matrix Language of SAS.

Entities:  

Mesh:

Year:  1992        PMID: 1568122     DOI: 10.1093/bioinformatics/8.1.23

Source DB:  PubMed          Journal:  Comput Appl Biosci        ISSN: 0266-7061


  6 in total

1.  Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients.

Authors:  Patrick Möhnle; Stephanie A Snyder-Ramos; Yinghui Miao; Alexander Kulier; Bernd W Böttiger; Jack Levin; Dennis T Mangano
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

2.  Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Sean M O'Brien
Journal:  Biometrics       Date:  2013-10-11       Impact factor: 2.571

3.  A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.

Authors:  Humam Kadara; Carmen Behrens; Ping Yuan; Luisa Solis; Diane Liu; Xuemin Gu; John D Minna; J Jack Lee; Edward Kim; Waun-Ki Hong; Ignacio I Wistuba; Reuben Lotan
Journal:  Clin Cancer Res       Date:  2010-12-16       Impact factor: 12.531

4.  A SAS macro for estimating direct adjusted survival functions for time-to-event data with or without left truncation.

Authors:  Zhen-Huan Hu; Hai-Lin Wang; Robert Peter Gale; Mei-Jie Zhang
Journal:  Bone Marrow Transplant       Date:  2021-08-19       Impact factor: 5.174

5.  Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.

Authors:  Rober C Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; Willian S Weintraub; Pierre Theroux
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

6.  Treatment patterns of prostate cancer with bone metastasis in Beijing: A real-world study using data from an administrative claims database.

Authors:  Yinchu Cheng; Lin Zhuo; Yuting Pan; Shengfeng Wang; Jihong Zong; Wentao Sun; Shuangqing Gao; Jian Lu; Siyan Zhan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-08       Impact factor: 2.890

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.